Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A S Bayer

Showing results (21-30 of 189) with videos related to

Pageof 19
Sort By:
Antimicrobial Agents and Chemotherapy|August 1, 1984
In vitro bactericidal synergy of gentamicin combined with penicillin G, vancomycin, or cefotaxime against group G streptococciK Lam, A S Bayer
Antimicrobial Agents and Chemotherapy|April 1, 1991
Beta-Lactam-beta-lactamase-inhibitor combinations are active in experimental endocarditis caused by beta-lactamase-producing oxacillin-resistant staphylococciL Hirano, A S Bayer
The Journal of Infectious Diseases|January 1, 1985
Efficacy of vancomycin plus rifampin in experimental aortic-valve endocarditis due to methicillin-resistant Staphylococcus aureus: in vitro-in vivo correlationsA S Bayer, K Lam
The American Journal of Medicine|October 1, 1983
Serious infections due to group G streptoccocci. Report of 15 cases with in vitro-in vivo correlationsK Lam, A S Bayer
Current Clinical Topics in Infectious Diseases|August 16, 2000
Update on culture-negative endocarditisL I Kupferwasser, A S Bayer
Chest|July 1, 1981
Fungal pneumonias. Part 3. Allergic bronchopulmonary aspergillosisR A Glimp, A S Bayer
Seminars in Arthritis and Rheumatism|February 1, 1979
Fungal arthritis. II. Coccidioidal synovitis: clinical, diagnostic, therapeutic, and prognostic considerationsA S Bayer, L B Guze
Disease-A-Month : DM|June 1, 1979
Staphylococcus aureus bacteremic syndromes: diagnostic and therapeutic updateA S Bayer, L B Guze
Chest|January 1, 1990
Immunopathogenetic aspects of infective endocarditisA S Bayer, A N Theofilopoulos
Chemotherapy|January 1, 1986
In vivo efficacy of azlocillin and amikacin versus ciprofloxacin with and without amikacin in experimental right-sided endocarditis due to Pseudomonas aeruginosaA S Bayer, K S Kim
Pageof 19

Showing results (21-30 of 189) with videos related to

Sort By:
Pageof 19
Antimicrobial Agents and Chemotherapy|August 1, 1984
In vitro bactericidal synergy of gentamicin combined with penicillin G, vancomycin, or cefotaxime against group G streptococciK Lam, A S Bayer
Antimicrobial Agents and Chemotherapy|April 1, 1991
Beta-Lactam-beta-lactamase-inhibitor combinations are active in experimental endocarditis caused by beta-lactamase-producing oxacillin-resistant staphylococciL Hirano, A S Bayer
The Journal of Infectious Diseases|January 1, 1985
Efficacy of vancomycin plus rifampin in experimental aortic-valve endocarditis due to methicillin-resistant Staphylococcus aureus: in vitro-in vivo correlationsA S Bayer, K Lam
The American Journal of Medicine|October 1, 1983
Serious infections due to group G streptoccocci. Report of 15 cases with in vitro-in vivo correlationsK Lam, A S Bayer
Current Clinical Topics in Infectious Diseases|August 16, 2000
Update on culture-negative endocarditisL I Kupferwasser, A S Bayer
Chest|July 1, 1981
Fungal pneumonias. Part 3. Allergic bronchopulmonary aspergillosisR A Glimp, A S Bayer
Seminars in Arthritis and Rheumatism|February 1, 1979
Fungal arthritis. II. Coccidioidal synovitis: clinical, diagnostic, therapeutic, and prognostic considerationsA S Bayer, L B Guze
Disease-A-Month : DM|June 1, 1979
Staphylococcus aureus bacteremic syndromes: diagnostic and therapeutic updateA S Bayer, L B Guze
Chest|January 1, 1990
Immunopathogenetic aspects of infective endocarditisA S Bayer, A N Theofilopoulos
Chemotherapy|January 1, 1986
In vivo efficacy of azlocillin and amikacin versus ciprofloxacin with and without amikacin in experimental right-sided endocarditis due to Pseudomonas aeruginosaA S Bayer, K S Kim
Pageof 19